Sinopharm Group Statistics

Total Valuation

Sinopharm Group has a market cap or net worth of HKD 57.36 billion. The enterprise value is 131.72 billion.

Market Cap	57.36B
Enterprise Value	131.72B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	Jun 16, 2025

Share Statistics

Sinopharm Group has 3.12 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	3.12B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	29.84%
Float	1.34B

Valuation Ratios

The trailing PE ratio is 7.64 and the forward PE ratio is 6.87. Sinopharm Group's PEG ratio is 0.89.

PE Ratio	7.64
Forward PE	6.87
PS Ratio	0.09
PB Ratio	0.68
P/TBV Ratio	0.77
P/FCF Ratio	5.93
P/OCF Ratio	n/a
PEG Ratio	0.89

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.21, with an EV/FCF ratio of 13.62.

EV / Earnings	17.56
EV / Sales	0.21
EV / EBITDA	5.21
EV / EBIT	6.51
EV / FCF	13.62

Financial Position

The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.60.

Current Ratio	1.39
Quick Ratio	1.02
Debt / Equity	0.60
Debt / EBITDA	3.39
Debt / FCF	8.41
Interest Coverage	6.54

Financial Efficiency

Return on equity (ROE) is 8.44% and return on invested capital (ROIC) is 5.61%.

Return on Equity (ROE)	8.44%
Return on Assets (ROA)	2.87%
Return on Invested Capital (ROIC)	5.61%
Return on Capital Employed (ROCE)	12.51%
Revenue Per Employee	5.75M
Profits Per Employee	69,324
Employee Count	108,217
Asset Turnover	1.51
Inventory Turnover	8.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.90% in the last 52 weeks. The beta is 0.81, so Sinopharm Group's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-9.90%
50-Day Moving Average	19.76
200-Day Moving Average	19.90
Relative Strength Index (RSI)	33.30
Average Volume (20 Days)	7,549,194

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sinopharm Group had revenue of HKD 622.02 billion and earned 7.50 billion in profits. Earnings per share was 2.41.

Revenue	622.02B
Gross Profit	47.10B
Operating Income	18.96B
Pretax Income	14.90B
Net Income	7.50B
EBITDA	21.47B
EBIT	18.96B
Earnings Per Share (EPS)	2.41

Full Income Statement

Balance Sheet

The company has 57.80 billion in cash and 81.29 billion in debt, giving a net cash position of -23.49 billion or -7.53 per share.

Cash & Cash Equivalents	57.80B
Total Debt	81.29B
Net Cash	-23.49B
Net Cash Per Share	-7.53
Equity (Book Value)	134.82B
Book Value Per Share	26.90
Working Capital	103.30B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.29 billion and capital expenditures -2.62 billion, giving a free cash flow of 9.67 billion.

Operating Cash Flow	12.29B
Capital Expenditures	-2.62B
Free Cash Flow	9.67B
FCF Per Share	3.10

Full Cash Flow Statement

Margins

Gross margin is 7.57%, with operating and profit margins of 3.05% and 1.21%.

Gross Margin	7.57%
Operating Margin	3.05%
Pretax Margin	2.40%
Profit Margin	1.21%
EBITDA Margin	3.45%
EBIT Margin	3.05%
FCF Margin	1.55%

Dividends & Yields

This stock pays an annual dividend of 0.73, which amounts to a dividend yield of 3.96%.

Dividend Per Share	0.73
Dividend Yield	3.96%
Dividend Growth (YoY)	6.22%
Years of Dividend Growth	4
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	3.96%
Earnings Yield	13.08%
FCF Yield	16.86%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sinopharm Group has an Altman Z-Score of 2.26. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.26
Piotroski F-Score	n/a